Goldman Sachs Group Inc Pulmonx Corp Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Pulmonx Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 253,756 shares of LUNG stock, worth $1.56 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
253,756
Previous 241,919 4.89%
Holding current value
$1.56 Million
Previous $1.53 Million 37.18%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$5.59 - $8.58 $66,168 - $101,561
11,837 Added 4.89%
253,756 $2.1 Million
Q2 2024

Aug 13, 2024
BUY
$5.77 - $9.82 $157,561 - $268,154
27,307 Added 12.72%
241,919 $1.53 Million
Q1 2024

May 15, 2024
SELL
$8.71 - $14.65 $329,255 - $553,799
-37,802 Reduced 14.98%
214,612 $1.99 Million
Q4 2023

Feb 13, 2024
BUY
$7.89 - $13.14 $1.11 Million - $1.84 Million
140,119 Added 124.78%
252,414 $3.22 Million
Q3 2023

May 14, 2024
SELL
$9.88 - $14.0 $1.38 Million - $1.96 Million
-140,119 Reduced 55.51%
112,295 $1.16 Million
Q3 2023

Nov 14, 2023
SELL
$9.88 - $14.0 $1.1 Million - $1.56 Million
-111,681 Reduced 49.86%
112,295 $1.16 Million
Q2 2023

May 14, 2024
BUY
$10.78 - $13.65 $775,577 - $982,062
71,946 Added 47.32%
223,976 $2.94 Million
Q2 2023

Aug 14, 2023
BUY
$10.78 - $13.65 $775,577 - $982,062
71,946 Added 47.32%
223,976 $2.94 Million
Q1 2023

May 14, 2024
SELL
$7.49 - $12.54 $1.42 Million - $2.38 Million
-189,494 Reduced 55.48%
152,030 $1.7 Million
Q1 2023

May 11, 2023
SELL
$7.49 - $12.54 $1.42 Million - $2.38 Million
-189,494 Reduced 55.48%
152,030 $1.7 Million
Q4 2022

May 14, 2024
SELL
$4.92 - $17.35 $1.64 Million - $5.78 Million
-333,210 Reduced 49.38%
341,524 $2.88 Million
Q4 2022

Feb 13, 2023
SELL
$4.92 - $17.35 $1.64 Million - $5.78 Million
-333,210 Reduced 49.38%
341,524 $2.88 Million
Q3 2022

May 14, 2024
BUY
$15.35 - $23.99 $3.59 Million - $5.6 Million
233,630 Added 52.96%
674,734 $11.2 Million
Q3 2022

Nov 10, 2022
BUY
$15.35 - $23.99 $3.59 Million - $5.6 Million
233,630 Added 52.96%
674,734 $11.2 Million
Q2 2022

May 14, 2024
BUY
$14.0 - $27.95 $2.64 Million - $5.27 Million
188,690 Added 74.75%
441,104 $6.49 Million
Q2 2022

Aug 15, 2022
SELL
$14.0 - $27.95 $838,852 - $1.67 Million
-59,918 Reduced 11.96%
441,104 $6.49 Million
Q1 2022

May 16, 2022
BUY
$21.13 - $35.65 $8.36 Million - $14.1 Million
395,566 Added 375.1%
501,022 $12.4 Million
Q4 2021

Feb 14, 2022
SELL
$29.72 - $45.1 $1.43 Million - $2.18 Million
-48,248 Reduced 31.39%
105,456 $3.38 Million
Q3 2021

Nov 10, 2021
BUY
$35.98 - $44.48 $5.53 Million - $6.84 Million
153,704 New
153,704 $5.53 Million

Others Institutions Holding LUNG

# of Institutions
124
Shares Held
31M
Call Options Held
300
Put Options Held
204K
View Full List

About Pulmonx Corp

LUNG Quotes by TradingView
  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $229M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email